This quality standard covers recognising, assessing and managing bipolar disorder in adults (aged 18 and over) in primary and secondary care. It describes high-quality care in priority areas for improvement.
It does not cover bipolar disorder in children and young people, which is included in NICE’s quality standard for bipolar disorder, psychosis and schizophrenia in children and young people.
In February 2016, statement 6 on valproate was removed and updated by a new statement in NICE’s quality standard for antenatal and postnatal mental health.
We checked this quality standard in 2017 and it is still up to date.
Next review: August 2018.